Skip to main content

Breast_Cancer News

3d rendered illustration of blood cells with droplets HDL-cholesterol and breast cancer risk
Genetic analyses suggest that high circulating HDL-cholesterol levels may increase breast cancer risk — a surprising finding since increased HDL-cholesterol is thought to be healthy.
Friday, January 24th, 2020
cancer in genetic code Study finds breast cancer recurrence score has different implications for men
A study published last year offered good news for women with early-stage ER-positive breast cancer who scored at intermediate risk for recurrence. However, a new study finds this conclusion may not directly apply to male patients with the same type of breast cancer
Monday, December 23rd, 2019
Pietenpol, Wilson land Komen cancer research support Pietenpol, Wilson land Komen cancer research support
Two Vanderbilt-Ingram Cancer Center investigators have received financial support from Susan G. Komen for breast cancer research.
Thursday, October 24th, 2019
pink bracelets for breast cancer awareness Another way to detect lymphedema
Early detection of lymphedema, which occurs in 20% of patients following breast cancer treatment, may improve therapeutic options for patients.
Tuesday, October 22nd, 2019
Xiao Ou Shu Study finds men have higher mortality rate after breast cancer diagnosis
A new study shows men with breast cancer are more likely to die than their female counterparts, across all stages of disease.
Thursday, October 17th, 2019
DNA analysis Study backs genetic testing for all metastatic breast cancer patients
Testing for all metastatic breast cancer patients may be an optimal strategy for identifying additional patients with increased risk as well as response to targeted therapies.
Friday, September 6th, 2019
women in pink Grant strengthens breast cancer research efforts
Breast cancer researchers at Vanderbilt-Ingram Cancer Center have secured a fourth round of continuous Specialized Program of Research Excellence funding.
Saturday, August 31st, 2019
dimmer switch A “rheostat” for cancer signals
 

Jason MacGurn and colleagues have characterized a “rheostat” that sets WNT pathway signaling in breast cancer cells.


Friday, August 30th, 2019
lung cancer metastasis Clinical study tests drug that may prevent cancer metastasis
A clinical study of a drug that may block cancer metastasis is currently enrolling patients at the Vanderbilt-Ingram Cancer Center.
Thursday, July 11th, 2019
Sheila Ridner and patient Technology better than tape measure for identifying lymphedema risk
 

Bioimpedance spectroscopy (BIS) is better than a tape measure for assessing a woman’s risk for developing lymphedema, painful swelling in the arm after breast cancer surgery, according to interim results of a recent study.


Friday, May 17th, 2019
cancer cells graphic Like racecars and geese, cancer cells draft their way to new tumor sites
 

Finding gives boost to fighting cancer through cell metabolism


Friday, April 5th, 2019
Breast cancer-killing RIG Breast cancer-killing RIG
A recent study in the journal Cancer Research demonstrates that a RIG-I agonist has potent immunogenic and therapeutic effects in breast cancer.
Friday, December 14th, 2018
Charles Caskey Mary Kay Foundation grant to bolster immunotherapy research
Charles Caskey, Ph.D., has received a cancer research grant from The Mary Kay Foundation to study how focused ultrasound therapy could be an ideal helper for immunotherapy.
Monday, October 22nd, 2018
Ingrid Mayer VICC breast cancer leaders named Komen Scholars
Ingrid Mayer, MD, MSCI, Ingram Professor of Cancer Research and leader of the Breast Cancer Research Program, has been named a Komen Scholar for her leadership in breast cancer research. She is joined by Wayne Dornan, PhD, a patient research advocate at VICC, who will serve on the Advocates in Science Steering Committee for Susan G. Komen.
Friday, April 13th, 2018
Justin Balko Study seeks to boost breast tumor immune response
 

Targeting specific molecules in breast tumors, called methylating agents, can turn up the immune response, potentially making tumors responsive to immunotherapy, suggests a new study published in Nature Communications.


Thursday, February 8th, 2018
Ingrid Mayer Study to test combination therapy for breast cancer
Vanderbilt-Ingram Cancer Center has received $2.3 million to fund a clinical research trial testing a combination of three immunotherapy compounds for patients with a specific type of advanced breast cancer.
Friday, October 27th, 2017
Ariella Hanker Investigators match novel cancer mutations with potential therapies
Research led by Vanderbilt-Ingram Cancer Center (VICC) investigators may have solved a mystery about why a targeted therapy stops working in a small group of breast cancer patients. They identified a novel gene mutation that develops in the tumors, and then found a different cancer drug that appears to treat the newly identified mutation. The […]
Monday, August 7th, 2017
Drivers of breast cancer metastasis Drivers of breast cancer metastasis
Overexpression of HER2 (human epidermal growth factor receptor 2) is found in about 25 percent of breast cancers and is associated with poor outcomes. HER2-amplified breast cancers use signaling through a complex of proteins called mTORC2 to drive tumor formation, tumor cell survival and resistance to HER2-targeted therapies. Rebecca Cook, Ph.
Thursday, July 27th, 2017
Arteaga to direct UT Southwestern cancer center Arteaga to direct UT Southwestern cancer center
Carlos L. Arteaga, M.D.
Thursday, July 13th, 2017
Breast cancer program lands new research grants Breast cancer program lands new research grants
Several investigators in Vanderbilt-Ingram Cancer Center’s (VICC) Breast Cancer Program have received grant awards to support translational research that may improve disease outcomes for patients. The grants totaling more than $3 million will fund mechanistic science and clinical trials designed to test novel therapy combinations and determine why some forms of breast cancer become resistant […]
Friday, March 24th, 2017
Precision medicine already changing cancer treatment strategies Precision medicine already changing cancer treatment strategies
The ability to test patients’ cancers for individual differences, mainly at the genetic level, and to make treatment decisions based on those differences is the hallmark of precision medicine, and Vanderbilt University Medical Center (VUMC) is among the leaders of this new approach to diagnosis and treatment. “Nationwide we’re seeing great promise with this approach […]
Thursday, May 26th, 2016
Public invited to learn about VICC precision cancer medicine Public invited to learn about VICC precision cancer medicine
Leading cancer investigators from Vanderbilt-Ingram Cancer Center will unveil the latest in cancer research during an upcoming community event. “Precision Medicine in Cancer: At the Crossroads of Research and Treatment for Patients” will be held Tuesday, May 10, from 5:
Friday, April 29th, 2016
Study explores how some breast cancers resist treatment Study explores how some breast cancers resist treatment
A targeted therapy for triple-negative breast cancer (TNBC), the most aggressive form of breast cancer, has shown potential promise in a recently published study. TNBC is the only type of breast cancer for which there are no currently approved targeted therapies. The new study led by Vanderbilt-Ingram Cancer Center (VICC) investigators has identified gene alterations […]
Thursday, April 21st, 2016
VICC’s Balko named a Susan G. Komen ‘Pink Tie Guy’ VICC’s Balko named a Susan G. Komen ‘Pink Tie Guy’
Justin Balko, Pharm.D., Ph.
Thursday, December 10th, 2015
Study seeks to ease ‘chemobrain’ for cancer patients Study seeks to ease ‘chemobrain’ for cancer patients
Many women who receive chemotherapy for breast cancer report problems with their thinking, memory and attention after treatment. And as the survival rates for breast cancer increase, so do these issues associated with chemotherapy. Paul Newhouse, M.
Monday, August 24th, 2015